Immediate Impact
1 by Nobel laureates 3 from Science/Nature 59 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
2025 Standout
Works of Weijian Guo being referenced
Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors
2021
Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Weijian Guo | 573 | 561 | 254 | 298 | 70 | 1.3k | |
| Wei Zhang | 437 | 362 | 259 | 397 | 55 | 1.3k | |
| Daniela Allende | 399 | 285 | 486 | 324 | 87 | 1.5k | |
| Markus Raderer | 583 | 370 | 260 | 195 | 61 | 1.4k | |
| Raphaël Saffroy | 481 | 336 | 257 | 548 | 78 | 1.7k | |
| Nicoletta Campanini | 831 | 420 | 207 | 478 | 69 | 1.6k | |
| Eun Yoon Cho | 538 | 373 | 246 | 369 | 50 | 1.6k | |
| Özgül Sağol | 442 | 197 | 295 | 314 | 99 | 1.1k | |
| Satoshi Matsusaka | 798 | 360 | 254 | 293 | 126 | 1.5k | |
| Akihiko Takeda | 536 | 325 | 730 | 700 | 54 | 1.7k | |
| Ru Jia | 803 | 308 | 155 | 407 | 46 | 1.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...